- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06068712
Proactive and Reactive Attention to Negative Templates
October 4, 2023 updated by: Lehigh University
EEG Measures during Visual Search Task.
In this line of research, the researchers having participants receive a positive (target) template cue, negative (distractor) template cue, or neutral (non-informative) template cue.
Note: This is a re-analysis of previously collected data.
Study Overview
Detailed Description
When finding a search target, receiving a target cue or distractor cue can increase search efficiency compared to a neutral cue.
The researchers are examining the neural basis of visual search when participants receive a positive (target) cue, negative (distractor) cue, or neutral (baseline) cue.
Note: This is a re-analysis of previously collected data.
Study Type
Interventional
Enrollment (Actual)
19
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Bethlehem, Pennsylvania, United States, 18015
- Lehigh University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- normal or corrected to normal visual acuity, normal color vision, no history of neurological disorders
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Within-Subjects Attentional Information
All Participants receive all levels of the attentional cue (target, distractor, or neutral cue).
|
Positive cue (target), negative cue (distractor), or neutral cue (baseline)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Button Press Reaction Time
Time Frame: During Testing (single day)
|
Speed to respond correctly to the target- after participant finds the target shape on a computer screen, they press a button to indicate what shape they see
|
During Testing (single day)
|
|
Button Press Accuracy
Time Frame: During Testing (single day)
|
Accuracy of responses to target item- we will measure whether the participants presses the correct button which corresponds to the target shape presented on the computer screen or the incorrect button
|
During Testing (single day)
|
|
Proactive EEG Activity
Time Frame: During Testing (single day)
|
Proactive (pre-search) Measures of EEG Theta Activity
|
During Testing (single day)
|
|
Reactive EEG Activity
Time Frame: During Testing (single day)
|
Reactive (post-search) Measures of EEG Alpha Activity
|
During Testing (single day)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nancy Carlisle, PhD, Lehigh University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 11, 2014
Primary Completion (Actual)
April 2, 2015
Study Completion (Actual)
April 2, 2015
Study Registration Dates
First Submitted
May 31, 2023
First Submitted That Met QC Criteria
October 4, 2023
First Posted (Actual)
October 5, 2023
Study Record Updates
Last Update Posted (Actual)
October 5, 2023
Last Update Submitted That Met QC Criteria
October 4, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 8R15EY030247-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
We plan to share anonymized subject data on Open Science Framework.
IPD Sharing Time Frame
Upon publication.
IPD Sharing Access Criteria
Open Science Framework internet access.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.